Navigation Links
Chlamydia Screening To Be Offered With Emergency Contraception

In an effort to identify and treat a potentially huge unknown population at risk of untreated Chlamydia, women requesting emergency contraception will be offered fast-tracked // screening for the disease.

Chlamydia, a sexually transmitted disease (STD) caused by a tiny bacterium, Chlamydia trachomatis, can lead to infertility, and is very common among young adults and teenagers. However, since Chlamydia may be mostly asymptomatic, most of the infected people are unaware that they harbor the disease.

Young women asking for the morning-after pill at pharmacies will be given a discreet plain purple box, containing a bottle for their urine sample, free postage and a confidential questionnaire offering them a variety of ways they can receive their diagnosis within three working days.

If the event of a Chlamydia diagnosis, they and their partner will then be referred to a genito-urinary clinic of their choice for full sexual health screening and treatment. The whole process from test to treatment should be completed in just two weeks.

The study is in response to a Department of Health drive for Primary Care Trusts to offer Chlamydia screening to under 25s in non genito-urinary clinic settings by April 2006.

The University of Manchester study, to be launched on 3 January 2006 and funded by The BUPA Foundation, hopes to screen 2,000 women at pharmacies.

Chlamydia screening will be offered to another 1,000 women asking for emergency contraception at family planning clinics and 400 asking for it at the Manchester Brook Advisory Service.

Those involved hope that important information will be gathered for the planning of screening in the Greater Manchester NHS region and possibly throughout the UK.

Chlamydia infection is very easily treated with just one dose of four tablets in the majority of cases, and timely diagnosis will be a boon for women concerned about sexually transmi tted infections.


'"/>




Related medicine news :

1. Chlamydia toxin- a secret killer
2. One In Nine Young Women Diagnosed With Chlamydia Infection
3. UK Govt Says On Course For National Chlamydia Screening
4. Home Chlamydia Test
5. Chlamydial Vaccine for Humans in the Pipeline
6. Mouse Model Demonstrates Immune System Reaction In Chlamydia Infection
7. Newly Identified Strains Of Chlamydia Trachomatis – A Gateway To New Disease
8. Chlamydia Vaccine a Step Closer to Reality
9. A Combined Research for Producing Chlamydia Vaccine Begins
10. Recurring Chlamydia Infections Common in Teenage Girls
11. Screening device for ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... celebrate the profession and recognize the positive impact veterinarians have on animal health ... and the World Organization for Animal Health (OIE) choose a theme each year ...
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Beginning in ... of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure ... changing the formula in the following ways:, , Removal of ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: